GW876008
GW876008 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
Treatment Of Patients With Social Anxiety Disorder
A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.
Clinical Trials (7)
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
A Study To Evaluate The Effect Of GW876008 On The Pharmacokinetics Of Oral Contraceptive Pills
Treatment Of Patients With Social Anxiety Disorder
A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.
A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.
An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7